Scholar Rock Holding Corporation (SRRK)

Nasdaq · Healthcare · Biotechnology
$48.13-4.45%As of 2026-11-22 · USD
Last session low $47.94Last session high $52.17
52-week low $38.6952-week high $61.76
Market cap
$5.87B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)58.4In the neutral range (30 to 70)
MACD (12, 26, 9)0.89Above its signal line (0.35); histogram 0.54
Bollinger %B (20, 2)74%Inside the bands (40.17 to 50.89)
SMA 2045.53Price is 5.7% above
SMA 5045.30Price is 6.2% above
SMA 20048.27Price is 0.3% below
ATR (20)5.22% of priceAverage true range per day
52-week position41%In the middle of the 38.69 to 61.76 range

About Scholar Rock Holding Corporation

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.

Latest fiscal yearEnded 2022-12-31: revenue of $33.19M and an operating margin of -404.8%.

More in Biotechnology